Other OTC - Delayed Quote • USD
NervGen Pharma Corp. (NGENF)
As of 9:43 AM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index
Return | NGENF | S&P/TSX Composite index |
---|---|---|
YTD | -25.00% | +6.41% |
1-Year | +29.66% | +9.22% |
3-Year | +30.21% | +16.54% |